Feasibility and Stage at Diagnosis for Children with Cancer: a Pilot Study on Population-based Data in a Middle-income Country Using the Toronto Childhood Cancer Stage Guidelines

Overview

Journal Ecancermedicalscience

Date 2025 Jan 16

PMID 39816388

Authors

Marceli de Oliveira Santos

Paulo Cesar Fernandes De Souza

Fernanda C da Silva de Lima

Nathalie V Balmant

Carolina Motta

Michele Goncalves da Costa

Rejane de Souza Reis

Gemma Gatta

Beatriz de Camargo

Affiliations

Soon will be listed here.

Abstract

Background: The aim was to conduct a pilot study in a middle-income country testing the use of the Toronto Childhood Cancer Staging System by Population-Based Cancer Registry (PBCR).

Methods: This study involved first the translation of the Australian pediatric cancer staging manual for 16 types of pediatric tumours. Four PBCRs from different regions of Brazil were selected for a pilot study. The study period was from 2005 to 2014, and data were collected from notification sources, including hospitals, pathological laboratories and routine medical records, and staging was done retrospectively.

Results: We identified 1,560 pediatric cancer cases diagnosed between 2005 and 2014. Notably, 94.7% met Tier 1 criteria, and 91.9% met Tier 2 criteria. The PBCR from Curitiba (south region) demonstrated higher staging feasibility (99.3% Tier 1; 96.7% Tier 2) than from Aracaju (northeast) (87.5% Tier 1; 81.3% Tier 2). Most cases had localised or regional disease (77.7%), while 14.3% were metastatic, and 8.0% could not be staged. Osteosarcoma had the highest metastasis rate (50.0%).

Conclusion: Our study demonstrates the feasibility of collecting pediatric cancer stage data from population-based registries in resource-limited settings, advancing our understanding of pediatric cancer outcomes in Brazil.

References

Youlden D, Baade P, Frazier A, Gupta S, Gottardo N, Moore A . Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000-2017. Acta Oncol. 2023; 62(10):1256-1264. DOI: 10.1080/0284186X.2023.2251668. View

Liu B, Abraham N, Chitsike I, Sylvie C, Kambugu J, Stevy N . Enhancing information on stage at diagnosis for childhood cancer in Africa. Pediatr Blood Cancer. 2023; 70(10):e30555. DOI: 10.1002/pbc.30555. View

Pineros M, Znaor A, Mery L, Bray F . A Global Cancer Surveillance Framework Within Noncommunicable Disease Surveillance: Making the Case for Population-Based Cancer Registries. Epidemiol Rev. 2017; 39(1):161-169. DOI: 10.1093/epirev/mxx003. View

Lins M, Amorim M, Vilela P, Viana M, Ribeiro R, Pedrosa A . Delayed diagnosis of leukemia and association with morbid-mortality in children in Pernambuco, Brazil. J Pediatr Hematol Oncol. 2012; 34(7):e271-6. DOI: 10.1097/MPH.0b013e3182580bea. View

Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard J . Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health. 2022; 6(6):409-431. DOI: 10.1016/S2352-4642(22)00095-5. View

Ghasemi D, Fleischhack G, Milde T, Pajtler K . The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma. Cancers (Basel). 2022; 14(3). PMC: 8833659. DOI: 10.3390/cancers14030679. View

Gupta S, Aitken J, Bartels U, Brierley J, Dolendo M, Friedrich P . Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines. Lancet Oncol. 2016; 17(4):e163-e172. DOI: 10.1016/S1470-2045(15)00539-2. View

de Aguirre-Neto J, de Camargo B, van Tinteren H, Bergeron C, Brok J, Ramirez-Villar G . International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study. JCO Glob Oncol. 2022; 8:e2100425. PMC: 9126524. DOI: 10.1200/GO.21.00425. View

Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J . Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. Lancet Oncol. 2013; 15(1):35-47. DOI: 10.1016/S1470-2045(13)70548-5. View

10.

Mallon B, Kabore R, Couitchere L, Akonde F, Narison M, Budiongo A . The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group. Pediatr Blood Cancer. 2023; 70(12):e30664. DOI: 10.1002/pbc.30664. View

11.

Sacerdote C, Mosso M, Alessi D, Merletti F, Tagliabue G, DAgostino A . An application of the Toronto Childhood Cancer Stage Guidelines in three population-based cancer registries: The case of central nervous tumors. Pediatr Blood Cancer. 2020; 67(6):e28303. DOI: 10.1002/pbc.28303. View

12.

Balmant N, de Paula Silva N, Santos M, de S Reis R, de Camargo B . Delays in the health care system for children, adolescents, and young adults with bone tumors in Brazil. J Pediatr (Rio J). 2018; 95(6):744-751. DOI: 10.1016/j.jped.2018.07.003. View

13.

Gatta G, Botta L, Capocaccia R, Canete A, Pritchard-Jones K . Staging childhood cancers in Europe: Application of the Toronto stage principles for neuroblastoma and Wilms tumour. The JARC pilot study. Pediatr Blood Cancer. 2021; 68(9):e29020. DOI: 10.1002/pbc.29020. View

14.

van den Heuvel-Eibrink M, Hol J, Pritchard-Jones K, van Tinteren H, Furtwangler R, Verschuur A . Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol. 2017; 14(12):743-752. DOI: 10.1038/nrurol.2017.163. View

15.

de Camargo B, de Andrea M, Franco E . Catching up with history: treatment of Wilms' tumor in a developing country. Med Pediatr Oncol. 1987; 15(5):270-6. DOI: 10.1002/mpo.2950150510. View

16.

Cotache-Condor C, Kantety V, Grimm A, Williamson J, Landrum K, Schroeder K . Determinants of delayed childhood cancer care in low- and middle-income countries: A systematic review. Pediatr Blood Cancer. 2022; 70(3):e30175. PMC: 10966942. DOI: 10.1002/pbc.30175. View

17.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M . Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125):1023-1075. PMC: 5879496. DOI: 10.1016/S0140-6736(17)33326-3. View

18.

Botta L, Gatta G, Didone F, Lopez Cortes A, Pritchard-Jones K . International benchmarking of childhood cancer survival by stage at diagnosis: The BENCHISTA project protocol. PLoS One. 2022; 17(11):e0276997. PMC: 9632762. DOI: 10.1371/journal.pone.0276997. View

19.

Youlden D, Frazier A, Gupta S, Pritchard-Jones K, Kirby M, Baade P . Stage at diagnosis for childhood solid cancers in Australia: A population-based study. Cancer Epidemiol. 2019; 59:208-214. DOI: 10.1016/j.canep.2019.02.013. View

20.

Petrilli A, de Camargo B, Filho V, Bruniera P, Brunetto A, Jesus-Garcia R . Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. J Clin Oncol. 2006; 24(7):1161-8. DOI: 10.1200/JCO.2005.03.5352. View